Hyperhidrosis doesn't behave the same way in every body area, and neither do the treatments. Aluminum chloride works excellently for axillary hyperhidrosis but is harder to use on hands and feet. Anticholinergics work more broadly but come with systemic side effects. Understanding why treatments differ by site helps patients and clinicians make better choices about which option is right for each affected area. This article covers the four main sites of focal hyperhidrosis, and what the evidence actually shows about treating each one.

Why Body Area Changes the Equation

The reason hyperhidrosis treatment varies so much by location comes down to fundamental differences in skin anatomy and physiology across the body.

Skin Thickness Varies Dramatically

Axillary skin is thin and highly permeable. Topical treatments penetrate quickly and evenly. Palmar and plantar skin, by contrast, are among the thickest on the body, the stratum corneum (the barrier layer) is substantially thicker. This means any topical medication needs much longer to penetrate, and higher concentrations may be required. A treatment that works overnight in the armpit may take days to work on the palms.

Sweat Gland Density Differs

Palms and soles have among the highest eccrine gland densities on the entire body, up to 600 glands per square centimeter. By contrast, axillary glands are more sparsely distributed. Higher density means there's simply more to suppress, and the cooling/thermoregulatory component is less dominant in these areas compared to the underarm.

Application Practicality Differs

Covering the axillae overnight with an occlusive wrap is straightforward. Maintaining an occlusive seal on the hands overnight is considerably harder, people move, use their hands at night, and gloves tend to slip. Feet are achievable with cotton socks, making them more practical. The face cannot be occluded at all, which rules out many topical approaches entirely.

Sweat Triggers Differ by Location

Axillary and plantar hyperhidrosis tend to have a stronger thermoregulatory component, people sweat more heavily in these areas when they're hot. Palmar and craniofacial (facial) hyperhidrosis are more driven by emotional and stress triggers. This distinction matters clinically because it affects how responsive each site is to different drug classes. Emotional sweating may respond better to systemic anticholinergics than thermoregulatory sweating does.

Axillary Hyperhidrosis (Underarms)

Axillary Hyperhidrosis
Most common site · Most responsive to treatment
Prevalence Axillary hyperhidrosis accounts for approximately 51% of focal hyperhidrosis cases and is the most common presentation.
First-line: Aluminum Chloride Aluminum chloride 20–25% is the gold-standard first-line treatment for axillary hyperhidrosis. The clinical response rate is 70–90%, and the evidence base is decades old with multiple randomized controlled trials. Aluminum chloride works because aluminum ions penetrate sweat gland ducts and cause temporary mechanical obstruction, followed by focal atrophy of secretory cells. The thin axillary skin and straightforward overnight occlusion protocol make this the ideal site for aluminum chloride. Patients apply the solution to completely dry skin before bed, cover with plastic wrap or a glove, and wash off in the morning.
Second-line: Glycopyrronium Topical Glycopyrronium bromide (the active ingredient in FDA-approved Qbrexza) is an excellent second-line option. The evidence base is strong, with large Phase 3 trials demonstrating meaningful axillary sweat reduction. Glycopyrronium crosses the blood-brain barrier less readily than oxybutynin, which translates to lower dry mouth incidence. It's particularly useful for patients who experience irritation from aluminum chloride or prefer not to use overnight occlusion.
Systemic options: Oral Anticholinergics Oral glycopyrrolate and oral oxybutynin are reserved for refractory axillary hyperhidrosis or when the patient has concurrent multi-site disease. They're effective but carry higher side effect burden than topical options and are not typically needed as monotherapy for axillary disease alone.
Iontophoresis and Botulinum Toxin Iontophoresis (electrical current delivery of ionic solutions) is not typically used for axillary hyperhidrosis because topical medications are so effective. Botulinum toxin injections are highly effective but require repeat injections every 6–12 months at significant cost, making them a later-line option.
Clinical verdict: The strongest evidence base and most treatment options available. Axillary hyperhidrosis is clinically the most responsive site to topical treatment.

Palmar Hyperhidrosis (Hands)

Palmar Hyperhidrosis
Second most common · Highly impactful on function
Clinical Impact Palmar hyperhidrosis is the second most common site. Because hands are constantly visible and used for handshakes, writing, typing, playing instruments, and using devices, sweaty palms create significant functional and social impairment. Wet hands affect grip, make writing difficult, damage electronics, and create social awkwardness.
Why Aluminum Chloride is Harder on Palms Palmar skin has a much thicker stratum corneum than axillary skin. This means aluminum chloride penetrates more slowly and less completely. Patients often need to maintain gloves or wraps overnight, bulkier and more uncomfortable than underarm occlusion, and require longer treatment duration (often 2–3 weeks) before seeing improvement. Results are less consistent than on axillae, and some patients need higher concentrations (25% rather than 20%).
Topical Oxybutynin Topical oxybutynin gel has a specific evidence base for palmar hyperhidrosis (notably from Glaser et al.). It's a reasonable option, though the evidence base is thinner than for oral oxybutynin. Systemic absorption of topical oxybutynin occurs, and some patients experience dry mouth even from topical application.
Oral Anticholinergics Oral glycopyrrolate and oral oxybutynin are highly effective for palmar hyperhidrosis because systemic delivery bypasses the skin penetration problem entirely. For many patients with inadequate response to topical aluminum chloride, adding or switching to oral medication provides meaningful control. Oral anticholinergics address the emotional/stress component of palmar sweating more effectively than topicals.
Iontophoresis Iontophoresis has very well-established evidence for palmar hyperhidrosis and represents a non-prescription option worth knowing about. Patients can purchase home iontophoresis devices and use them regularly. This is a realistic alternative for motivated patients who want to avoid systemic medication.
Clinical verdict: Harder to treat topically than axillary hyperhidrosis due to skin thickness. Systemic anticholinergics are often needed for adequate control. Iontophoresis is a well-evidenced non-systemic alternative.

Plantar Hyperhidrosis (Feet)

Plantar Hyperhidrosis
Common · Frequently co-occurs with palmar
Clinical Consequences Plantar hyperhidrosis is common and frequently occurs alongside palmar hyperhidrosis. The practical consequences are significant: wet socks and shoes, persistent foot odor from bacterial overgrowth in the moist environment, maceration (softening and breakdown of the skin), and markedly increased risk of fungal infections like athlete's foot (tinea pedis).
Aluminum Chloride for Feet Plantar skin is among the thickest on the body, rivaling palmar thickness. Aluminum chloride penetrates slowly and unpredictably. Maintaining cotton socks overnight (necessary for occlusion) is more tolerable than gloves but still cumbersome. Results are variable, some patients get good response, others get minimal improvement. The skin thickness barrier limits effectiveness for many patients.
Managing Secondary Complications Part of plantar hyperhidrosis management involves controlling the secondary effects of constant moisture. Antifungal powders, breathable footwear, rotating shoes to allow them to dry, and moisture-wicking socks all help reduce odor and infection risk.
Oral Anticholinergics Oral glycopyrrolate and oral oxybutynin are effective for plantar hyperhidrosis because systemic delivery bypasses skin thickness limitations. For many patients, oral medication provides more reliable control than topical approaches. This is one of the clearer indications for systemic treatment, when topical options have failed or provided inadequate results.
Clinical verdict: Often requires oral medication for meaningful control. Topical treatments can help but results are limited by skin thickness. Secondary management of fungal risk and odor is important.

Craniofacial Hyperhidrosis (Face, Scalp, Forehead)

Craniofacial Hyperhidrosis
Less common but highly visible · Significant social impact
Prevalence and Impact Craniofacial hyperhidrosis (affecting the face, scalp, and forehead) occurs in approximately 22% of focal hyperhidrosis patients. Despite being less common than axillary or palmar hyperhidrosis, it often creates outsized social and professional impact because facial sweating is visible, difficult to conceal, and frequently triggered by stress, exactly the situations where appearance matters most.
Why Aluminum Chloride Doesn't Work Aluminum chloride cannot be used on the face. The alcohol base is too harsh for facial skin, causing significant irritation and erythema. Occlusion is impossible, people cannot occlude their face overnight. The combination of these factors makes aluminum chloride unsuitable regardless of potential efficacy.
Topical Oxybutynin (First-line) Topical oxybutynin gel has the strongest evidence base for facial hyperhidrosis. It can be applied as a gel to the forehead and scalp and avoids many of the irritation issues associated with aluminum chloride. The evidence comes from clinical practice and some controlled studies. Systemic absorption occurs but is typically lower than oral dosing, though some patients still experience dry mouth.
Oral Anticholinergics Oral glycopyrrolate and oral oxybutynin are effective for facial hyperhidrosis and useful for severe or refractory cases. They address the emotional trigger component of facial sweating well. The trade-off is systemic side effects, dry mouth is common at therapeutic doses.
Botulinum Toxin Injections Botulinum toxin can be effective for forehead and localized facial sweating. The benefit is that it addresses a specific area without systemic effects. The drawbacks are cost and the need for repeat injections every 3–6 months.
Surgical Sympathectomy (Not Recommended) Endoscopic thoracic sympathectomy (ETS), surgical cutting of sympathetic nerves, was historically used for severe hyperhidrosis. However, it's now controversial and not recommended by most specialists as a first- or second-line option. The major issue is compensatory sweating: up to 90% of patients develop heavy sweating in other body areas (back, abdomen, groin) after the procedure. This can be more functionally disabling than the original hyperhidrosis. For these reasons, ETS is reserved only for exceptional cases with severe, refractory hyperhidrosis where all other options have failed.
Clinical verdict: Topical and oral anticholinergics are the mainstay. Aluminum chloride is not suitable. The emotional trigger component makes this site particularly responsive to stress reduction and anxiolytic approaches alongside pharmacotherapy.

Multi-Site Hyperhidrosis: A Clinical Strategy

Many patients have hyperhidrosis affecting more than one body site simultaneously. This creates a clinical decision point: treat each site with the most effective topical option, or switch to an oral medication that addresses all sites at once?

The advantage of oral anticholinergics in multi-site disease is that a single medication addresses sweating across all affected areas. A patient with concurrent palmar, plantar, and axillary hyperhidrosis can take one dose of oral glycopyrrolate and get benefit across all three sites, rather than managing separate topical protocols for each area. This simplifies adherence and reduces the burden of daily management.

The trade-off is higher systemic side effect burden. Oral anticholinergics cause dry mouth and other anticholinergic effects more consistently than topical approaches. The dosing also must account for side effects, titrating up until efficacy is achieved but before tolerability becomes problematic.

A practical hybrid approach is increasingly used: aluminum chloride for axillary hyperhidrosis (the most responsive site) combined with low-dose oral anticholinergic for palmar and/or plantar disease. This leverages the strengths of each, potent topical on the most responsive site, systemic medication for the harder-to-treat areas, while keeping systemic side effect burden lower than monotherapy with oral medication alone.

Treatment Suitability by Body Area

Here's how the major treatment options rank across the four main sites:

Body Area Aluminum Chloride Topical Anticholinergic Oral Anticholinergic
Axillary (Underarms) Excellent Good Effective
Palmar (Hands) Moderate Good Excellent
Plantar (Feet) Moderate Limited Excellent
Craniofacial (Face) Not suitable Excellent Excellent
A clinical reality. Hyperhidrosis management is often iterative. A patient might start with aluminum chloride for axillary disease, discover it's insufficient for their palms, and add topical oxybutynin. If that's still not enough, they might transition to oral glycopyrrolate. Or they might find a topical protocol works and decline systemic medication despite being candidates for it. The goal is identifying the effective regimen the patient will actually adhere to, because the best treatment is the one they use consistently.

Back to all articles Join the waitlist →